Lena Jendeberg
Director/Board Member at ATTANA AB
Profile
Lena Jendeberg is currently working as a Director at Attana AB since 2018.
Prior to this, she worked as a Vice President-Development at Modus Therapeutics AB.
Dr. Jendeberg holds a doctorate degree from the Royal Institute of Technology.
Lena Jendeberg active positions
| Companies | Position | Start |
|---|---|---|
| ATTANA AB | Director/Board Member | 01/01/2018 |
Former positions of Lena Jendeberg
| Companies | Position | End |
|---|---|---|
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Corporate Officer/Principal | - |
Training of Lena Jendeberg
| Royal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ATTANA AB | Health Services |
| Private companies | 1 |
|---|---|
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
- Stock Market
- Insiders
- Lena Jendeberg
